ResMed | RMD - 债务利息支出

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 540.43M

USD 4.06B

USD 1.35B

USD 843.17M

股息收益率

USD 1.04

USD 499.81M

USD 568.84M

USD 8.16K

EPS每股收益

USD 0.27

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 775K

USD 59K

USD 404.17M

USD 34.6B

USD 398.73M

USD 931.6M

USD 499.81M

普通股股本

USD 145.04M

21.77

USD 502.31M

USD 1.43B

销售和管理费用

USD 285.66M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 1.05B

	债务利息支出	更改		日
Ansell	USD 20.6M		300K	2025-12
Avita Medical	AUD 1.25M		100K	2025-06
Cochlear	AUD 6.3M		3.65M	2025-12
CSL	USD 215M		111M	2025-12
Fisher & Paykel Healthcare	NZD 4.8M		700K	2026-06
Healius	AUD 32.8M		15.4M	2024-12
Integral Diagnostics	AUD 5.34M		6.08M	2024-06
Mayne Pharma	AUD 1.2M		50K	2024-06
Nanosonics	AUD 779K		94K	2025-06
Polynovo	AUD 506K		130K	2025-06
Ramsay Health Care	AUD 300.6M		15.5M	2025-12
Regis Healthcare	AUD 150K		30.92M	2025-12
ResMed	USD 775K		886K	2024-12
Sigma Healthcare	AUD 7.97M		365K	2024-01
Sonic Healthcare	AUD 86.91M		43.94M	2024-12
Telix Pharmaceuticals	AUD 19.39M		11.77M	2026-06